Sleep and Glycemic Control in Type 2 Diabetes Adolescents

NARecruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

September 16, 2020

Primary Completion Date

May 31, 2026

Study Completion Date

May 31, 2026

Conditions
Type 2 Diabetes
Interventions
BEHAVIORAL

Loss frame sleep extension intervention

Aim 2 will be an interventional study design utilizing Fitbit and text messaging to perform a loss-framed incentive intervention designed to motivate participants to increase their sleep duration. Glycemic control will be measured via laboratory testing of hemoglobin A1c and Libre continuous glucose monitoring (CGM) for 2 weeks pre- and post-intervention. A focus group will be conducted prior to this intervention with patients ineligible for the intervention in order to determine appropriate text messaging.

Trial Locations (1)

19104

RECRUITING

Children's Hospital of Philadelphia, Philadelphia

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Children's Hospital of Philadelphia

OTHER